Ambrisentan and hepatic enzyme increased Patient Reports February 11, 2012



Ambrisentan Side Effects Report #5400988-6
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, weighting 269.0 lb, was diagnosed with pulmonary hypertension What is  pulmonary hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: atrial fibrillation What is  atrial fibrillation, hepatic enzyme increased, hypervolaemia, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, SILDENAFIL CITRATE, WARFARIN, FUROSEMIDE, LISINOPRIL, DILTIAZEM, GLIPIZIDE, SALSALATE. Patient was hospitalized. Patient recovered.

Ambrisentan Side Effects Report #5803855-9
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension What is  pulmonary hypertension, oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: arthralgia, hepatic enzyme increased, international normalised ratio increased, oedema peripheral, pain in extremity, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized and became disabled. Patient recovered.

Ambrisentan Side Effects Report #5835934-4
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 29, 2008. Female patient, weighting 196.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: hepatic enzyme increased. Ambrisentan dosage: unknown. During the same period patient was treated with REVATIO, WARFARIN, HYDROCHLOROTHIAZIDE, ATENOLOL, ASPIRIN, CALCIUM. Patient recovered.

Ambrisentan Side Effects Report #5885640-5
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2008. Female patient, weighting 196.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: hepatic enzyme increased. Ambrisentan dosage: unknown. During the same period patient was treated with REVATIO, WARFARIN, HYDROCHLOROTHIAZIDE, ATENOLOL, ASPIRIN, CALCIUM. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Ambrisentan